Venmax Drugs & Pharmaceuticals Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 4.04 | 1.62 | 1.32 |
| Operating Expense | 3.93 | 1.58 | 1.27 |
| Net Profit | 0.11 | 0.03 | 0.02 |
| Net Profit Margin | 2.72% | 1.85% | 1.52% |
| Earning Per Share | 0.21 | 0.05 | 0.05 |
| EBIDTA | 0.11 | 0.04 | 0.04 |
| Effective Tax Rate | 0% | 25% | 40% |
Particulars
Mar 2026
Revenue4.04
Operating Expense3.93
Net Profit0.11
Net Profit Margin2.72
Earning Per Share0.21
EBIDTA0.11
Effective Tax Rate0
